New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
May 8, 2015
10:10 EDTVRTXPiper confident in Vertex getting positive panel vote for Orkambi
Piper Jaffray said the briefing documents posted for next Tuesday's advisory committee meeting on Vertex's Orkambi combo drug did not raise any new or surprise safety concerns and that the efficacy concerns raised do not "hold much water" when compared to the unmet clinic benefit of the drug. The firm said it remains confident in a positive panel vote and approval of the drug by the May 5 PDUFA date and reiterate kits Overweight rating and $146 price target on Vertex shares.
09:28 EDTVRTXOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTVRTXFDA staff question if Vertex CF drug combo adds benefit over ivacaftor alone
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use